SION · Categories · Form 4

SION - SEC Form 4 insider transactions

Sionna Therapeutics Inc. (SION) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SION

• 4d
  SEC Form 4 filed by Thompson Peter A.

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 4d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 9d
  SEC Form 4 filed by Thompson Peter A.

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 9d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 50d
  Chief Legal Officer Fitzpatrick Jennifer exercised 10,250 shares at a strike of $6.11 and sold $347,019 worth of shares (10,250 units at $33.86) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 80d
  Director Thompson Peter A. sold $1,379,866 worth of shares (30,953 units at $44.58) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 80d
  Director Orbimed Advisors Llc sold $1,379,866 worth of shares (30,953 units at $44.58) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 89d
  Large owner Tpg Gp A, Llc sold $10,000,000 worth of shares (250,000 units at $40.00) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 109d
  SEC Form 4 filed by Chief Medical Officer Mckee Charlotte

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 109d
  SEC Form 4 filed by Chief Legal Officer Fitzpatrick Jennifer

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 109d
  SEC Form 4 filed by President & CEO Cloonan Michael

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 109d
  SEC Form 4 filed by Chief Business Officer Beer Caroline Stark

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 109d
  SEC Form 4 filed by CFO Ridloff Elena

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 117d
  Director Orbimed Advisors Llc sold $1,486,010 worth of shares (33,356 units at $44.55) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 117d
  Director Thompson Peter A. sold $1,486,010 worth of shares (33,356 units at $44.55) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 127d
  Director Orbimed Advisors Llc sold $83,428 worth of shares (1,875 units at $44.49) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 127d
  Director Thompson Peter A. sold $83,428 worth of shares (1,875 units at $44.49) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 137d
  Chief Legal Officer Fitzpatrick Jennifer exercised 10,250 shares at a strike of $6.11 and sold $415,330 worth of shares (10,250 units at $40.52) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 150d
  Director Orbimed Advisors Llc sold $4,814,205 worth of shares (108,073 units at $44.55) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 150d
  Director Thompson Peter A. sold $4,814,205 worth of shares (108,073 units at $44.55) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 152d
  Director Ra Capital Management, L.P. sold $1,200,704 worth of shares (30,316 units at $39.61) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 157d
  Director Ra Capital Management, L.P. sold $5,500,158 worth of shares (136,351 units at $40.34) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 179d
  Director Ra Capital Management, L.P. sold $14,762,604 worth of shares (373,610 units at $39.51) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 185d
  President & CEO Cloonan Michael exercised 99,800 shares at a strike of $6.11 and sold $3,618,560 worth of shares (99,800 units at $36.26) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 186d
  Director Booth Bruce sold $3,041,683 worth of shares (88,878 units at $34.22) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 187d
  Director Booth Bruce sold $9,251,102 worth of shares (286,369 units at $32.30) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 190d
  President & CEO Cloonan Michael exercised 25,200 shares at a strike of $6.11 and sold $788,153 worth of shares (25,200 units at $31.28) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 192d
  Director Booth Bruce sold $5,939,784 worth of shares (194,932 units at $30.47) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 201d
  Director Booth Bruce sold $1,485,790 worth of shares (49,546 units at $29.99) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 205d
  SEC Form 4 filed by Chief Business Officer Beer Caroline Stark

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 206d
  Director Booth Bruce sold $2,367,473 worth of shares (78,693 units at $30.08) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 208d
  President & CEO Cloonan Michael exercised 25,000 shares at a strike of $6.11 and sold $727,798 worth of shares (25,000 units at $29.11) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 233d
  Chief Legal Officer Fitzpatrick Jennifer exercised 10,250 shares at a strike of $6.11 and sold $236,980 worth of shares (10,250 units at $23.12) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 234d
  CFO & Head of Corp. Dev. Ridloff Elena sold $240,442 worth of shares (9,584 units at $25.09), decreasing direct ownership by 20% to 38,532 units (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 240d
  President & CEO Cloonan Michael exercised 25,000 shares at a strike of $6.11 and sold $624,361 worth of shares (25,000 units at $24.97) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 240d
  CFO & Head of Corp. Dev. Ridloff Elena sold $601,858 worth of shares (23,416 units at $25.70), decreasing direct ownership by 33% to 48,116 units (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 248d
  President & CEO Cloonan Michael exercised 25,000 shares at a strike of $6.11 and sold $568,750 worth of shares (25,000 units at $22.75) (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 248d
  CFO & Head of Corp. Dev. Ridloff Elena sold $1,124,335 worth of shares (52,000 units at $21.62), decreasing direct ownership by 42% to 71,532 units (SEC Form 4)

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Viney Joanne L.

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Thompson Peter A.

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Stelzer Laurie

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Ruddy Marcella K.

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Resnick Joshua

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Fleming Harold Edward

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 313d
  SEC Form 4 filed by Director Clancy Paul J

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)
• 314d
  SEC Form 4 filed by Director Booth Bruce

  4 - Sionna Therapeutics, Inc. (0002036042) (Issuer)

Other SION categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends